Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

Maja de Jonge; Ate van der Gaast; AST Planting; L van Doorn; ALI Boot; J Wanders; M Satomi; Jaap Verweij

doi:10.1158/1078-0432.CCR-04-1937

Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

Maja de Jonge
, Ate van der Gaast
, AST Planting
, L van Doorn
, ALI Boot
, J Wanders
, M Satomi
, Jaap Verweij

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3806-3813
Number of pages	8
Journal	Clinical Cancer Research
Volume	11
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-04-1937
Publication status	Published - 2005

Research programs

EMC MM-03-86-08

Access to Document

10.1158/1078-0432.CCR-04-1937

http://hdl.handle.net/1765/54765

Cite this

@article{93e26d4b4d474f87ac20f03afc5a9f42,

title = "Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors",

author = "\{de Jonge\}, Maja and \{van der Gaast\}, Ate and AST Planting and \{van Doorn\}, L and ALI Boot and J Wanders and M Satomi and Jaap Verweij",

year = "2005",

doi = "10.1158/1078-0432.CCR-04-1937",

language = "Undefined/Unknown",

volume = "11",

pages = "3806--3813",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

de Jonge, M, van der Gaast, A, Planting, AST, van Doorn, L, Boot, ALI, Wanders, J, Satomi, M & Verweij, J 2005, 'Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors', Clinical Cancer Research, vol. 11, no. 10, pp. 3806-3813. https://doi.org/10.1158/1078-0432.CCR-04-1937

TY - JOUR

T1 - Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

AU - de Jonge, Maja

AU - van der Gaast, Ate

AU - Planting, AST

AU - van Doorn, L

AU - Boot, ALI

AU - Wanders, J

AU - Satomi, M

AU - Verweij, Jaap

PY - 2005

Y1 - 2005

U2 - 10.1158/1078-0432.CCR-04-1937

DO - 10.1158/1078-0432.CCR-04-1937

M3 - Article

C2 - 15897580

SN - 1078-0432

VL - 11

SP - 3806

EP - 3813

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -